Skip to main content Accessibility help
×
Hostname: page-component-cd9895bd7-fscjk Total loading time: 0 Render date: 2024-12-24T12:27:57.719Z Has data issue: false hasContentIssue false

5 - Governance in the Era of CRISPR and DIY-Bio

Regulatory Guidance of Human Genome Editing at the National and Global Levels

from Part I - Consumer Genetic Technologies: Rights, Liabilities, and Other Obligations

Published online by Cambridge University Press:  27 August 2021

I. Glenn Cohen
Affiliation:
Harvard Law School, Massachusetts
Nita A. Farahany
Affiliation:
Duke University School of Law
Henry T. Greely
Affiliation:
Stanford University School of Law
Carmel Shachar
Affiliation:
Harvard Law School, Massachusetts
Get access

Summary

This chapter analyzes the technology of human genome editing with a focus on the ethical issues involved and offers guidance as how best to regulate this technology. First, this chapter explains several common types of gene editing technologies and then analyzes the ethical implications of the two primary therapeutic uses of gene editing: somatic and germline. Primary ethical analysis will focus on the bioethical principles of autonomy, beneficence, non-maleficence, and social justice; analysis will then provide a weighing of these principles and likely consequences–noting the biologic differences between somatic versus germline treatments. Somatic gene editing is generally more confined to the individual, while germline editing changes the genes of cells that are passed sexually to offspring, thus having the power to shape the human genome generationally--the ultimate consequence of which is the influence and shaping of human evolution. In conclusion, the chapter argues the consequences of somatic vs. germline genome editing demand that, when considering the proper emphasis of a regulatory paradigm, somatic editing should be regulated under a nationally guided framework and germline editing should be regulated under both a nationally and globally guided framework.

Type
Chapter
Information
Consumer Genetic Technologies
Ethical and Legal Considerations
, pp. 65 - 76
Publisher: Cambridge University Press
Print publication year: 2021

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Save book to Kindle

To save this book to your Kindle, first ensure [email protected] is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×